Results 201 to 210 of about 4,909,303 (275)
Factors Associated With Bilateral Involvement in Non‐Infectious Labyrinthitis: A Case–Control Study
Non‐infectious labyrinthitis may progress from unilateral to bilateral inner‐ear involvement, resulting in greater functional impairment. In this retrospective case–control study of 50 patients, younger age, female sex, and the presence of systemic disease were associated with bilateral involvement. These exploratory findings may help identify patients
Douglas Henderson +9 more
wiley +1 more source
Letter: Upadacitinib in Perianal Crohn's Disease: Does Clinical Closure Reflect True Remission? [PDF]
Saward G, Heerasing N.
europepmc +1 more source
Abstract Preoperative parenteral nutrition (PN) improves outcomes in malnourished surgical patients. Traditionally, this requires hospital admission, increasing length of stay and costs—challenges worsened by limited hospital bed availability. Outpatient PN may offer a feasible alternative.
Narisorn Lakananurak, Leah Gramlich
wiley +1 more source
Isolated Rectal Polypoid Lesion as the Initial Presentation of Crohn's Disease. [PDF]
Chen J, Hatfield B, Bohl JL, Tariq R.
europepmc +1 more source
Multifaceted burden of short bowel syndrome for patients and caregivers: The landmark survey
Abstract Background Short bowel syndrome is a debilitating condition often requiring long‐term parenteral support to maintain hydration, nutrition, and survival. Methods As part of the noninterventional, cross‐sectional Landmark Survey study, we evaluated burdens associated with short bowel syndrome and parenteral support dependency from patient and ...
Jenny E. Harrison +11 more
wiley +1 more source
Evolving role of intestinal ultrasound in the evaluation of Crohn's disease: A clinical- radiological perspective. [PDF]
Maccioni F +3 more
europepmc +1 more source
Abstract Background Home parenteral nutrition (HPN) is the standard of care for adults with chronic intestinal failure (CIF), but evidence from publicly funded healthcare systems in middle‐income countries is limited. This study describes an 11‐year experience of a structured, nursing‐led HPN program within Brazil's Unified Health System (SUS ...
Tatiana da Cunha Rana +5 more
wiley +1 more source
Abstract Mirikizumab is a p19‐directed anti‐interleukin‐23 antibody approved for the treatment of adults with moderate‐to‐severe ulcerative colitis (UC). Here, we report the first data of mirikizumab pharmacokinetics (PK) and exposure–response (E/R) relationships in pediatric participants (aged 2 to <18 years weighing >10 kg) with moderate‐to‐severe UC
Yuki Otani +5 more
wiley +1 more source
The Changing Landscape in Patients With Crohn's Disease. [PDF]
Ong S, Seenan JP.
europepmc +1 more source

